Skip to main content
Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.740
-0.070 (-2.49%)
At close: Feb 27, 2026, 4:00 PM EST
2.720
-0.020 (-0.74%)
After-hours: Feb 27, 2026, 7:39 PM EST

Absci Revenue

Absci had revenue of $378.00K in the quarter ending September 30, 2025, a decrease of -77.78%. This brings the company's revenue in the last twelve months to $2.82M, down -33.09% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.

Revenue (ttm)
$2.82M
Revenue Growth
-33.09%
P/S Ratio
146.37
Revenue / Employee
$17,930
Employees
157
Market Cap
412.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.53M-1.18M-20.71%
Dec 31, 20235.72M-29.00K-0.50%
Dec 31, 20225.75M965.00K20.18%
Dec 31, 20214.78M2.00K0.04%
Dec 31, 20204.78M2.72M132.04%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 161.32M
Niagen Bioscience 124.71M
Century Therapeutics 113.34M
Enanta Pharmaceuticals 66.98M
LENZ Therapeutics 17.50M
Verastem 13.38M
Immutep 5.28M
Upstream Bio 2.80M
Revenue Rankings

ABSI News

More News